Antigen avidity potentiates the durability of the vaccine immune response
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aee5273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Nicole G Weidner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Antibody Affinity, Antigens, AIDS Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
The protective benefits of vaccination can critically depend on the durability of the corresponding immune response. However, the factors influencing vaccine durability are poorly understood. Here, we tested whether antigen avidity (i.e., cumulative multivalent binding strength) affected the durability, magnitude, and diversity of the humoral immune response in preclinical HIV vaccine models. We developed neoteric mosaic nanoparticle platforms to vary antigen avidity through precise modulation of its key constituents, epitope affinity and valency, while keeping other variables constant. High-valency immunogens elicited durable and clonally diverse memory B cell (MBC) responses that were detectable for more than 1 year postprime. Increased antigen valency also drove the formation and persistence of long-lived plasma cells (LLPCs) as well as epitope-specific serum antibody responses. This appeared to be due, in part, to more robust and durable germinal center (GC) reactions that were elicited by high-valency immunogens and were detectable for upward of 6 months postprime. High-valency antigens also promoted B cell responses in a clinically relevant homologous prime-boost regimen. The positive effects of antigen avidity in driving productive B cell responses were independent of antigen dose and adjuvant. However, when interclonal competition was suppressed, MBC, LLPC, and late GC responses to low-avidity immunogens were rescued. Affinity worked in concert with valency to drive the formation of MBC responses, with valency having strong influences. Collectively, the results underscore the importance of antigen avidity in eliciting durable and diverse vaccine responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
- Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
- IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
- Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.
- Moderna Inc., Cambridge, MA 02142, USA.
ORCID-Profile: Nicole G Weidner, Mauricio V Padilla, Layne Pruitt, Christopher A Cottrell, Kristyn Gonzales, Oleksandr Kalyuzhniy, Danny Lu, Nushin Alavi, Nicole Phelps, Maisha Aniqua, Kristy M Waldrep, Emma J Keller, Meredith Weglarz, William R Schief, Robert K Abbott
Förderung
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
- McLaughlin Endowment
- University of Texas Medical Branch
Zitieren
APA
Weidner, N. G., Padilla, M. V., Pruitt, L., Cottrell, C. A., Gonzales, K., Kalyuzhniy, O., Lu, D., Alavi, N., Phelps, N., Aniqua, M., Waldrep, K. M., Keller, E. J., Weglarz, M., Schief, W. R., & Abbott, R. K. (2026). Antigen avidity potentiates the durability of the vaccine immune response. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aee5273
Vancouver
Weidner NG, Padilla MV, Pruitt L, Cottrell CA, Gonzales K, Kalyuzhniy O, et al. Antigen avidity potentiates the durability of the vaccine immune response. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aee5273
BibTeX
@article{Weidner2026,
author = {Weidner, Nicole G and Padilla, Mauricio V and Pruitt, Layne and Cottrell, Christopher A and Gonzales, Kristyn and Kalyuzhniy, Oleksandr and Lu, Danny and Alavi, Nushin and Phelps, Nicole and Aniqua, Maisha and Waldrep, Kristy M and Keller, Emma J and Weglarz, Meredith and Schief, William R and Abbott, Robert K},
title = {Antigen avidity potentiates the durability of the vaccine immune response},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aee5273}
}
EUVIMED